glp 1 and mood Glucagon-like Peptide-1 receptor agonists as emerging therapeutics in bipolar disorder: a narrative review of preclinical clinical evidence GLP-1 Therapy Chicago & Northbrook
Description
Vulnerably sharing with you today
The drug does something to Alzheimer's biology - the question is when to use it.
Only 34% of GLP-1 on DPP-4 inhibitors were still taking DPP-4 inhibitors 52 weeks after starting GLP-1 therapy, according to our pharmacy claims data.
Mounjaro hit $23 billion, and Zepbound added $13.5 billion
Compatible with many small TRT-style vials and similar containers
